Actively Recruiting
AI-Based Mobile Intervention on Medication Non-Adherence and Transition
Led by University of Central Florida · Updated on 2026-05-01
200
Participants Needed
2
Research Sites
30 weeks
Total Duration
On this page
Sponsors
U
University of Central Florida
Lead Sponsor
A
American Epilepsy Society
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to examine whether the AI-personalized version of the Medilepsy® app is more effective than the non-AI (standard version without AI personalization) can improve key outcomes, such as medical adherence and transition readiness, among underserved adolescents and young adults with epilepsy, ages 14-24, in Florida, USA. Outcomes are organized into primary (effectiveness), secondary (usability), and exploratory (language experience) endpoints.
CONDITIONS
Official Title
AI-Based Mobile Intervention on Medication Non-Adherence and Transition
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with epilepsy
- Currently prescribed anti-seizure medicine (ASMs)
- Identified as part of an underserved population, including racial or ethnic groups historically underrepresented in research or healthcare, or low-income status
- Aged 14-17 years and able to provide assent with a parent or legally authorized representative to receive app notifications
- Aged 18-24 years and able to provide informed consent
- Able to read, speak, and write in English
- Resides in Florida
- Receives outpatient medical services
You will not qualify if you...
- Does not own a mobile device with internet access
- Has a history of severe intellectual disability
- Unable to operate a mobile device (keyboard or touchscreen)
- Resides in an in-patient setting
- Adults unable to provide consent
- Pregnant women
- Prisoners
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Orlando Health
Orlando, Florida, United States, 32806
Actively Recruiting
2
University of Central Florida
Orlando, Florida, United States, 32827
Actively Recruiting
Research Team
M
Michelle Tall, PhD, RN, FAES
CONTACT
A
Amoy Fraser, PhD, CCRP, PMP
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here